Cancer is a leading cause of death in Europe, and its prevalence is set to 
increase with an ageing population. Reducing cancer and its consequences 
is a major priority for European Commission. This scientific opinion focuses 
on improving the participation in existing screening programmes for 
cervical, colorectal and breast cancers and examines the extension of
screening programmes to other cancers.
The GCSA recommends, among others, extending breast cancer screening 
to women below 50 as well as extending the screening programmes to 
lung and prostate cancer. For these and other cancers, the GCSA advises 
„living-guidelines” allowing rapid improvements of screening programs. 
Scientific developments should be continuously reviewed, and guidelines 
updated regularly, to adapt novel cancer screening technologies.